KalshiComprobar disponibilidadKYC requeridoDatos de resolución verificadosBien calibradoAviso de calidad de datosDatos de la fuente degradados
Datos del 29 oct 2026, 16:41 UTC · política pm-quality-4
Punto medio del libro seleccionado
before April 2027 · —
Cargando el libro seleccionado…
—
Precio guardado
before April 2027 70.5%Líder entre 6 opciones
before April 2027 70.5%Calidad del mercado
49 / 100
Baja calidadVolumen 24h
4,5 €
Interés abierto
21,9 mil US$
Interés abierto medioCompra / Venta
— / —
before April 2027Spread
—
Datos de mercado
Actualizado hace 50 minutos
Retrasado24 mar 26, 14:00 UTC1 ene 27, 15:00 UTC
El gráfico y los cambios muestran probabilidades históricas guardadas, no el libro seleccionado en directo.
Tendencias
Fila seleccionada: punto medio del libro. Otras filas: referencias guardadas, posiblemente normalizadas; los cambios de 24h usan el historial guardado.
before OctoberPerdida
before SeptemberPerdida
Condiciones de la plataforma
Fuente: Kalshi
Estas condiciones son informativas; las operaciones simuladas de CoinRithm siguen sus propias reglas.
- Cierre anticipado:
- Sí
- Plazo de liquidación:
- 30m (informativo)
Profundidad de mercado · before April 2027
Cargando el libro seleccionado…
—
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Will WHO classify the current hantavirus outbreak as a Public Health Emergency of International Concern by end of 2026?
Manifold MarketsHow many human screwworm cases will be reported in the United States in 2026?
KalshiWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiNew pandemic in 2026? [Polymarket]
Manifold MarketsWhich countries will have an Ebola case in 2026?
PolymarketDid COVID-19 come from a laboratory?
Manifold MarketsReglas
If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.
Reglas de cada resultado
- before April 2027
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.
- before 2027
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Jan 1, 2027, then the market resolves to Yes.
- before December
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Dec 1, 2026, then the market resolves to Yes.
- before November
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Nov 1, 2026, then the market resolves to Yes.
- before October
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Oct 1, 2026, then the market resolves to Yes.
- before September
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.